home · filing · 0001104659-21-133657
8-K filed November 3, 2021, 7:59 PM ET
ticker CGTX
CIK 0001455365
leadership
confidence high
sentiment neutral
materiality 0.40
Cognition Therapeutics appoints Ellen Richstone to board; director Breedlove resigns
COGNITION THERAPEUTICS INC
Board increased from six to seven directors; Ellen B. Richstone appointed as Class I director effective Nov 1, 2021.
Richstone will chair the Audit Committee and qualifies as audit committee financial expert under SEC rules.
Received option to purchase 16,670 shares at $12.10 per share, vesting monthly over 36 months.
Director Mark H. Breedlove notified resignation effective Dec 31, 2021; decision not due to any disagreement with the company.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2021-12-31
Filed November 3, 2021, 7:59 PM ET
On October 29, 2021, Mark H. Breedlove notified the Board that he intends to resign as a member of the Board, effective December 31, 2021.
Effective 2021-11-01
Filed November 3, 2021, 7:59 PM ET
Effective November 1, 2021, in connection with the Board Increase, the Board appointed Ellen B. Richstone to serve as a Class I member of the Board
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Mark H. Breedlove resigned as Director at COGNITION THERAPEUTICS INC.
Action resigned
Role Director
Exact text from the filing
On October 29, 2021, Mark H. Breedlove notified the Board that he intends to resign as a member of the Board, effective December 31, 2021.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Ellen B. Richstone was appointed as Class I Director at COGNITION THERAPEUTICS INC.
Action appointed
Role Class I Director
Exact text from the filing
Effective November 1, 2021, in connection with the Board Increase, the Board appointed Ellen B. Richstone to serve as a Class I member of the Board
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-21-133657
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.